V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220009165 | 220003710 | 1.64 | null | Palliative (P) | 2016-05-11 | 2016-05-11 | Vemurafenib | null | N | 220036057 | CABAZITAXEL |
| 220009167 | 220003712 | null | 74.6 | Palliative (P) | 2016-08-20 | 2016-08-20 | OCTREOTIDE | N | N | 220036060 | DACARBAZINE |
| 220009168 | 220003713 | null | 49 | Disease modification (D) | 2014-02-06 | 2014-02-18 | Vemurafenib | N | N | 220036061 | IBRUTINIB |
| 220009169 | 220003714 | null | 99.4 | Palliative (P) | 2012-04-29 | 2014-11-18 | CAPECITABINE + RT | 0 | Y | 220036062 | VEMURAFENIB |
| 220009170 | 220003715 | 1.73 | 79.5 | Palliative (P) | 2017-10-08 | 2017-10-16 | Capecitabine | N | N | 220036063 | CISPLATIN + ETOPOSIDE |
| 220009171 | 220012010 | 1.63 | 74.8 | Palliative (P) | 2014-10-14 | 2014-10-14 | IDARUBICIN + MITOXANTRONE + Tretinoin | 02 | N | 220036066 | IRINOTECAN + MDG |
| 220009172 | 220012010 | null | 71.5 | Palliative (P) | 2017-04-30 | 2017-05-05 | Fludarabine + Melphalan RIC Allo | N | N | 220036066 | CETUXIMAB + IRINOTECAN + MDG |
| 220009173 | 220003716 | 1.9 | 100.2 | Palliative (P) | 2016-08-07 | 2017-08-18 | Cyclophosphamide+Fludara+TBI Allo | N | N | 220036071 | VEMURAFENIB |
| 220009174 | 220003716 | 1.66 | 53.7 | Palliative (P) | 2013-06-26 | 2013-06-26 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 2 | N | 220036071 | DABRAFENIB |
| 220009175 | 220003716 | 1.57 | 71.5 | Palliative (P) | 2015-06-15 | 2015-06-18 | AML LI-1 Trial | 2 | N | 220036071 | CISPLATIN + ETOPOSIDE |
| 220009176 | 220003716 | -1 | 79 | Palliative (P) | 2004-04-13 | 2017-08-11 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 220036071 | ECARBOX |
| 220009177 | 220003716 | null | null | Palliative (P) | 2016-04-12 | 2016-04-30 | CISPLATIN + ETOPOSIDE | 02 | N | 220036071 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 220009178 | 220003717 | 1.75 | 66.35 | Palliative (P) | 2015-08-20 | 2015-08-25 | BEP 3 day | null | null | 220036087 | CETUXIMAB |
| 220009179 | 220003718 | 1.73 | 60.3 | Palliative (P) | 2013-09-03 | 2013-09-04 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 2 | Y | 220036088 | CAPECITABINE |
| 220009180 | 220003719 | null | null | Palliative (P) | 2018-01-03 | 2018-01-03 | CHOP R - 21 days | N | null | 220036089 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 220009183 | 220016491 | 1.6 | 85 | Palliative (P) | 2016-04-01 | 2016-04-03 | Arsenic Triox + Tretinoin Ind W1-4 | 02 | N | 220036094 | CARBOPLATIN + PEMETREXED |
| 220009184 | 220003721 | null | 103 | Palliative (P) | 2016-09-10 | 2016-09-17 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220036096 | IPILIMUMAB + NIVOLUMAB |
| 220009185 | 220012013 | null | -1 | Curative (C) | 2013-11-15 | 2013-12-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | 220036098 | FLUDARABINE + MELPHALAN |
| 220009186 | 220003722 | null | null | Palliative (P) | 2015-11-01 | 2015-11-04 | Paclitaxel 7 day | N | N | 220036100 | IPILIMUMAB + NIVOLUMAB |
| 220009187 | 220003723 | 1.69 | 65 | Adjuvant (A) | 2015-04-08 | 2015-04-13 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE | 2 | N | 220036103 | IDARUBICIN |
| 220009189 | 220012014 | 1.57 | 68 | Palliative (P) | 2017-09-01 | 2017-09-06 | FEC 100 | 2 | N | 220036111 | CAPECITABINE + TEMOZOLOMIDE |
| 220009193 | 220019057 | 1.8 | 85.9 | Palliative (P) | 2017-08-12 | 2017-08-12 | DABRAFENIB | 02 | N | 220036118 | CAPECITABINE + CARBOPLATIN |
| 220009194 | 220019057 | null | null | Palliative (P) | 2015-10-10 | 2015-10-19 | OCTREOTIDE | null | null | 220036118 | CTD |
| 220009195 | 220021335 | 1.57 | 68 | Palliative (P) | 2014-11-09 | 2014-11-09 | Alemtuzumab(INTRAVENOUS) | N | N | 220036121 | CAPECITABINE + CARBOPLATIN |
| 220009196 | 220003726 | null | null | Palliative (P) | 2016-07-31 | 2016-08-07 | Mitox + Tretinoin Spanish Course 3 | N | N | 220036124 | DACARBAZINE |
| 220009197 | 220003726 | null | null | Palliative (P) | 2014-04-08 | 2014-04-08 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | Y | N | 220036124 | RUXOLITINIB |
| 220009198 | 220003727 | null | null | Palliative (P) | 2013-12-04 | 2013-12-04 | BUSULFAN | N | N | 220036130 | MITOXANTRONE |
| 220009199 | 220003728 | 1.63 | 65 | null | 2013-10-05 | 2013-10-08 | Fludarabine + Melphalan RIC Allo | N | Y | 220036133 | CAPECITABINE |
| 220009200 | 220003729 | 1.59 | 63.15 | Palliative (P) | 2018-01-15 | 2018-01-15 | UKALL 14 TRIAL | N | N | 220036138 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 220009201 | 220003730 | 1.72 | 60.5 | Palliative (P) | null | 2016-07-03 | Carboplatin + Pemetrexed | N | N | 220036139 | CAPECITABINE + IRINOTECAN |
| 220009202 | 220003731 | 1.6 | 73 | Palliative (P) | 2013-02-09 | 2013-02-09 | BOSUTINIB | 02 | null | 220036142 | CAPECITABINE |
| 220009203 | 220003732 | 1.67 | 64.7 | Palliative (P) | 2014-05-07 | 2014-05-26 | Carboplatin + Pemetrexed | N | N | 220036143 | CAPECITABINE |
| 220009204 | 220003732 | 1.6 | 75 | Adjuvant (A) | 2013-05-04 | 2013-05-05 | Vemurafenib | 02 | N | 220036143 | CISPLATIN + FLUOROURACIL |
| 220009206 | 220003734 | null | null | Palliative (P) | 2015-02-23 | 2015-02-23 | OCTREOTIDE | N | N | 220036147 | PACLITAXEL |
| 220009207 | 220012018 | 1.62 | 45.2 | Not known (9) | 2016-10-05 | 2016-10-18 | Mitoxantrone | 02 | N | 220036150 | ARSENIC TRIOXIDE + TRETINOIN |
| 220009208 | 220012018 | null | null | Curative (C) | 2016-07-18 | 2016-07-18 | Arsenic trioxide + Tretinoin | Y | N | 220036150 | CARBOPLATIN + RT |
| 220009209 | 220003735 | 1.5 | null | Palliative (P) | 2017-08-30 | 2017-09-08 | Arsenic trioxide + Tretinoin | null | N | 220036155 | PACLITAXEL |
| 220009210 | 220003735 | 1.73 | 92.4 | Curative (C) | 2014-08-09 | 2014-08-09 | Melphalan oral | 01 | N | 220036155 | CISPLATIN |
| 220009211 | 220003736 | 1.75 | 74.1 | Palliative (P) | null | 2013-06-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 220036162 | LANREOTIDE |
| 220009212 | 220003736 | 1.7 | null | Palliative (P) | 2015-12-14 | 2015-12-15 | Bortezomib +/- Dexamethasone | N | N | 220036162 | TOPARP TRIAL |
| 220009213 | 220003737 | 1.84 | 96.6 | Palliative (P) | 2016-01-23 | 2016-02-20 | MACE | N | N | 220036164 | MITOXANTRONE |
| 220009214 | 220003738 | 1.81 | null | Palliative (P) | 2015-01-03 | 2015-01-04 | RUXOLITINIB | 02 | N | 220036166 | TEMOZOLOMIDE |
| 220009215 | 220003738 | 1.64 | 74 | Palliative (P) | 2016-03-18 | 2016-03-18 | IDARUBICIN | N | N | 220036166 | RUXOLITINIB |
| 220009216 | 220003738 | 1.81 | 84 | Palliative (P) | 2015-04-20 | 2015-05-15 | Pemetrexed | null | null | 220036166 | CTD |
| 220009217 | 220003738 | 1.53 | null | Curative (C) | null | 2014-08-05 | Cisplatin + Pemetrexed | null | null | 220036166 | CYCLOPHOSPHAMIDE |
| 220009218 | 220003739 | 1.56 | 0 | Curative (C) | null | 2014-07-19 | IPILIMUMAB + NIVOLUMAB | N | N | 220036174 | TRIPLE INTRATHECAL |
| 220009219 | 220003739 | 1.8 | 69.9 | Palliative (P) | 2017-11-03 | 2017-11-15 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | 220036174 | CAPECITABINE |
| 220009220 | 220003740 | 1.8 | 95 | Palliative (P) | 2016-05-30 | 2016-05-31 | AML LI-1 Trial | null | null | 220036176 | LENALIDOMIDE |
| 220009221 | 220003741 | 1.55 | 98.7 | Palliative (P) | 2016-07-18 | 2016-08-02 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 220036177 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 220009222 | 220003741 | 0 | 0 | Palliative (P) | 2017-11-28 | 2017-12-03 | Midostaurin | N | N | 220036177 | FCIST |